Comparative evaluation of Levetiracetam 1000 mg extended release tablet once daily formulation with Levetiracetam 500 mg immediate release tablet twice daily formulation by assessing pharmacokinetic parameters in healthy human subjects

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced